These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8388609)

  • 21. Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by promoter methylation and silencing of the retinoic acid receptor-beta.
    Oshita F; Sekiyama A; Suzuki R; Ikehara M; Yamada K; Saito H; Noda K; Miyagi Y
    Oncol Rep; 2003; 10(1):105-8. PubMed ID: 12469153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of lung cancer--state of the art in 2000].
    Nakanishi Y; Inoue K; Hara N
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term results of small cell lung cancer treated by surgery combined with postoperative chemotherapy: a report of 65 patients].
    Zhang X; Sun Y; Huang J
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):137-9. PubMed ID: 10743080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
    Miller AA; Rosner GL; Ratain MJ; Hollis DR; Green MR; Schilsky RL
    Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of treatment of recurrent small-cell lung cancer.
    Hosp Med; 1999 Mar; 60(3):220. PubMed ID: 10476252
    [No Abstract]   [Full Text] [Related]  

  • 26. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
    Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer.
    Leighl NB; Goss GD; Lopez PG; Burkes RL; Dancey JE; Rahim YH; Rudinskas LC; Pouliot JF; Rodgers A; Pond GR; Shepherd FA
    Lung Cancer; 2006 Jun; 52(3):327-32. PubMed ID: 16597474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
    J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential sensitivity patterns in small cell lung cancer cell lines: detection and circumvention of resistance to topoisomerase II targeting drugs.
    Jensen PB
    Dan Med Bull; 1994 Nov; 41(5):475-88. PubMed ID: 7859516
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation of flow cytometric and microdensitometric DNA content analysis in lung cancer.
    Kuo SH; Lee YC; Liu YR; Lee YT; Luh KT; How SW
    Anal Quant Cytol Histol; 1994 Feb; 16(1):25-8. PubMed ID: 8011038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear DNA content as an indicator of chemosensitivity in small-cell carcinoma of the lung.
    Abe S; Tsuneta Y; Makimura S; Itabashi K; Nagai T; Kawakami Y
    Anal Quant Cytol Histol; 1987 Oct; 9(5):425-8. PubMed ID: 2823846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small cell cancer of lung; rapid tumor necrosis leading to serious pulmonary infections after intensive chemotherapy.
    Brandman JR; Ruckdeschel JC; O'Donnell MR; Horton J
    N Y State J Med; 1981 Aug; 81(9):1332-4. PubMed ID: 6267528
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cytological features of small cell lung cancer--relation between nuclear chromatin change and chemotherapeutic effect].
    Fu WL; Wan LZ; Dong W
    Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):127-9. PubMed ID: 2820681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of nuclear DNA content in small cell carcinoma of the lung.
    Abe S; Makimura S; Itabashi K; Nagai T; Tsuneta Y; Kawakami Y
    Cancer; 1985 Oct; 56(8):2025-30. PubMed ID: 2992755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferating activity, DNA ploidy changes of lung cancer cells before and after chemotherapy.
    Mroz RM; Chyczewska E; Holownia A; Izycki T; Chyczewski L; Braszko JJ
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():161-2. PubMed ID: 11820586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell kinetic-directed sequential chemotherapy with cyclophosphamide and adriamycin in T1699 mammary tumors.
    Braunschweiger PG; Schiffer LM
    Cancer Res; 1980 Mar; 40(3):737-43. PubMed ID: 7471093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cell proliferation kinetics in sarcoma 37. I. The changes in the size of the cell and the nucleus over the generative cycle].
    Kristov K; Grashev G; Krusteva K
    Eksp Med Morfol; 1980; 19(3):136-41. PubMed ID: 7418643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.